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Abstract
Background: A modest number of prospective studies of the composition of the intestinal
microbiota and eczema in early life have yielded conflicting results.
Objective:  To examine the relationship between the bacterial diversity of the gut and the
development of eczema in early life by methods other than stool culture.
Methods: Fecal samples were collected from 21 infants at 1 and 4 months of life. Nine infants were
diagnosed with eczema by the age of 6 months (cases) and 12 infants were not (controls). After
conducting denaturating gradient gel electrophoresis (DGGE) of stool samples, we compared the
microbial diversity of cases and controls using the number of electrophoretic bands and the
Shannon index of diversity (H') as indicators.
Results: Control subjects had significantly greater fecal microbial diversity than children with
eczema at ages 1 (mean H' for controls = 0.75 vs. 0.53 for cases, P = 0.01) and 4 months (mean H'
for controls = 0.92 vs. 0.59 for cases, P = 0.02). The increase in diversity from 1 to 4 months of
age was significant in controls (P = 0.04) but not in children who developed eczema by 6 months
of age (P = 0.32).
Conclusion:  Our findings suggest that reduced microbial diversity is associated with the
development of eczema in early life.
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Background
Eczema is often the first manifestation of atopy in infants
who will develop asthma or allergic rhinitis later in child-
hood [1]. The prevalence of atopic diseases such as
eczema has been on the rise for several decades, particu-
larly in industrialized nations [2,3]. Potential explana-
tions for the increased prevalence of eczema and other
atopic diseases include reduced exposure to microbial
agents (the "hygiene hypothesis"[4]) and/or changes in
the gut microbiota in early life [5].
Few prospective studies have examined the relation
between the composition of the gut microbiota in early
life and atopy [6-9]. A study of 324 European infants fol-
lowed from birth to age 18 months found that neither
time to gut colonization with 11 bacterial groups nor ratio
of strict anaerobic to facultative anaerobic bacteria in cul-
tures from neonatal stool samples was associated with
eczema or food allergy [7]. In contrast, a study of 957
Dutch infants showed that the presence of C. difficile in
stool samples at age 1 month (assessed by quantitative
real-time PCR) was associated with increased risks of
eczema, recurrent wheeze, and allergic sensitization at age
2 years [8]. In that study, early colonization with E. coli
was associated with eczema by parental report but not
with objectively diagnosed eczema. The conflicting results
of these studies may be due to differences in statistical
power and/or limited ability to adequately culture the
complex gut microbiota [10].
Novel methods such as analysis of bacterial 16S ribos-
omal DNA [rDNA] (using universal primers or denaturat-
ing techniques) [11,12] are much more sensitive for
detecting certain bacterial species in the mouth or gut
than traditional cultures. Using temporal temperature gra-
dient gel electrophoresis (TTGE), Li and colleagues found
a significant difference in the diversity of the oral microbi-
ota of children with and without severe dental caries [13].
Using a similar approach, Wang and colleagues recently
reported that reduced diversity of the gut microbiota at
age 1 week is associated with eczema in the first 18
months of life [9].
We performed denatured gradient gel electrophoresis
(DGGE) analysis of bacterial 16S rDNA genotypes on
stool samples to assess whether the microbial diversity of
the gut microbiota at ages 1 and 4 months is associated
with the development of eczema in early life. We report
that reduced microbial diversity of the neonatal gut
microbiota in the first 4 months of life is associated with
an increased risk of eczema at age 6 months.
Methods
Study cohort
Pregnant women were recruited between July 2003 and
November 2005 from three outpatient facilities affiliated
with Brigham and Women's Hospital in Boston at their
24-week prenatal visit, as previously described [14]. Inclu-
sion criteria were maternal age between 18 years and 44
years; plans to deliver at Brigham and Women's Hospital;
and maternal ability to speak English or Spanish.
Informed consent was obtained from participating moth-
ers. Of the 37 participating neonates, nine had been diag-
nosed with eczema by a physician before age 6 months
and were included as cases for this analysis. Twelve
healthy children (no diagnosis of eczema) were then
matched to the cases on gender and included as control
subjects for this study. The study was approved by the
Institutional Review Board of Brigham and Women's Hos-
pital.
A questionnaire was administered to each participating
woman between her 24-week prenatal visit and delivery to
obtain information on demographics, general health, and
history of allergic diseases and/or symptoms for each of
the child's parents.
Information on labor and delivery was obtained from
review of medical records. When the child was 2 and 6
months of age, a telephone questionnaire (modified from
the American Thoracic Society-Division of Lung Diseases
questionnaire[15]) was administered by trained research
assistants to the child's primary caretaker.
Stool collection and denatured gradient gel 
electrophoresis (DGGE) analysis of bacterial 16S rDNA in 
stool samples
A stool sample was collected from participating neonates
at ages 1 and 4 months. More than a gram of stool was col-
lected into a sterile specimen container and frozen for
transport to the laboratory. Approximately 0.05 gram of
stool specimen was placed into a 1.5 ml sterile tube. Fol-
lowing the fecal DNA purification protocol supplied by
the manufacturer, DNA was extracted using the Extract-
Master Fecal DNA extraction kit (EPICENTRE Biotechno-
logics, Madison, WI). The V2–V3 region of the 16S rDNA
gene of bacteria in the fecal samples was amplified using
the primers described by Tannock et al [16]. PCR was per-
formed using a Biorad thermal cycler and 0.2 ml tubes.
The reaction mixture (50 μL) contains Platinum PCR
SuperMix High Fidelity (Invitrogen, Carlsbad CA), 1 unit
of Platinum Taq DNA Polymerase High Fidelity (Invitro-
gen), 20 pmol of each primer and 4 μl of fecal DNA.
Amplification was 94°C for 3 minutes, 30 cycles of 94°C
for 30 s, 56°C for 30 s, 68°C for 60 s and 7 minutes at
68°C at the end of the cycles. DGGE was performed using
the DCode universal mutation detection system (Bio-RadClinical and Molecular Allergy 2008, 6:11 http://www.clinicalmolecularallergy.com/content/6/1/11
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Laboratories, Hercules CA) in gels that were 16 cm × 16
cm by 1 mm; 6% polyaccrylamide gels were prepared and
electrophoresed with 1× tris-acetate EDTA (TAE) buffer
prepared from 50× TAE buffer. The denaturing gradient
was formed by using two 6% polyacrylamide stock solu-
tions containing a 20–55% urea/formamide gradient that
increases in the direction of electrophoresis. A 100%
denaturing solution containing 40% formamide and 7.0
M urea was used. Electrophoresis was performed at 130 V
and 60°C for approximately 4 hours. The electrophoresis
was stopped when a xylene cyanol dye marker reached the
bottom of the gel. Gels were stained with ethidium bro-
mide solution (5 μg/mL) for 20 minutes, washed with
deionized water and viewed using a Gel Doc UV transillu-
mination system (Bio-Rad).
Statistical analysis
The number of DGGE bands was used as an indicator of
fecal bacterial diversity for each participating child, both
at 1 and at 4 months of age. Densitometric curves were
obtained for all the bands in each sample, and the relative
intensity of each band in the sample (pi) was computed.
Shannon diversity indices (H') were then calculated for
each patient at 1 and 4 months of age, using the formula
H' = -Σ pi* ln(pi)[17].
Univariate analysis for baseline characteristics was per-
formed using Mann-Whitney rank-sum tests. The differ-
ences in bacterial diversity between cases and controls at
each point in time (1 and 4 months of age) were tested by
Mann-Whitney rank-sum tests and by logistic regression
modeling; non-parametric analysis was repeated after
stratification by mode of delivery. We explored the behav-
ior of bacterial diversity over time using mixed effects lin-
ear modeling in order to account for correlations between
repeated measures on the same subjects [18]. An interac-
tion term between time and eczema status was included to
assess the differential effect of time in the two groups. All
statistical analysis was performed using SAS v9.1 (SAS
Institute Inc., Cary, NC).
Results
Table 1 shows the main characteristics of participating
children. Approximately half of the children were girls (by
matching design) who were born by vaginal delivery and
who were breastfed. There were no significant differences
in breastfeeding, mode of delivery, birthweight, 5-minute
APGAR score, day care attendance, or use of antibiotics
between children who did and did not develop eczema by
age 6 months.
The results of the analysis of the mean number of DGGE
bands (representing bacterial 16S rDNA profiles, see Fig-
Table 1: Characteristics of participating children
Total n (%) Eczema1 n (%) Controls n (%) P-value2
Gender:
-Male 11 (52.4) 4 (44.4) 7 (58.3) 0.67
Mode of delivery: 0.67
-Vaginal 10 (47.6) 5 (55.6) 5 (41.7)
-Cesarean 11 (52.4) 4 (44.4) 7 (58.3)
Maternal history of atopy 12 (57.1) 7 (77.8) 5 (41.7) 0.18
Term delivery3 17 (81.0) 7 (77.8) 10 (83.3) 1.00
Birthweight (g), mean (SD) 3319 (688) 3192 (395) 3415 (851) 0.24
5-minute APGAR, median 9 9 9 0.50
Breastfed 11 (52.4) 6 (66.7) 5 (41.7) 0.39
Daycare attendance 5 (23.8) 1 (11.1) 4 (33.3) 0.34
Use of antibiotics4 3 (18.8) 1 (16.7) 2 (20.0) 1.00
Measures of bacterial diversity:
DGGE bands5, mean (95%CI):
-1 month of age 4.4 (3.6–5.1) 3.8 (2.6–4.9) 4.8 (3.8–5.9) 0.10
-4 months of age 5.3 (3.8–6.7) 3.9 (2.3–5.4) 6.5 (4.2–8.8) 0.06
Shannon index6, mean (95%CI):
-1 month of age 0.66 (0.55–0.76) 0.53 (0.38–0.67) 0.75 (0.63–0.88) 0.01
-4 months of age 0.77 (0.62–0.91) 0.59 (0.38–0.81) 0.92 (0.76–1.08) 0.02
1 Defined as parental report of physician-diagnosed eczema at or before 6 months of age. 2Mann-Whitney P-values for the comparison between 
cases with eczema and controls.
3Birth between 37 and 41 weeks of gestation.
4Maternal report of antibiotic administration to the child
5Number of denaturating gradient gel electrophoresis (DGGE) bands in each sample
6Shannon H' index calculated using the relative intensity of all bands in each sampleClinical and Molecular Allergy 2008, 6:11 http://www.clinicalmolecularallergy.com/content/6/1/11
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ure 1) and the Shannon diversity indices in participating
children are included in Table 1 and illustrated in Figure
2. There was a trend for a higher mean number of bands
in controls than in children with eczema at 1 month of
life, with a more pronounced difference at 4 months. Sim-
ilarly, controls had significantly higher indices of diversity
(H') than cases, both at 1 and at 4 months. The observed
differences in the index of diversity at ages 1 and 4 months
remained statistically significant after adjustment for
mode of delivery and maternal history of atopy (data not
shown).
We then examined the relation between increasing bacte-
rial diversity and eczema in bivariate analyses using logis-
tic regression (Table 2). At age 1 month, an increment in
the Shannon diversity index from the mean value for cases
(0.53) to the mean value for controls (0.75) was associ-
ated with a 70% reduction in the odds of eczema by age 6
months. There was a similar yet nonstatistically significant
trend for an inverse association between the number of
electrophoretic bands and eczema. At age 4 months, an
increment in the number of bands from the mean value
for cases (3.9) to the mean value for controls (6.5) was
associated with a 75% reduction in the odds of eczema by
age 6 months. In addition, an increment in the Shannon
diversity from the mean value for cases (0.59) to the mean
value for controls (0.92) at age 4 months was associated
with an 85% reduction in the odds of eczema. The results
of analyses of microbial diversity and eczema were not
appreciably changed after adjustment for relevant covari-
ates (Table 2).
Because of the known influence of mode of delivery on
the neonatal gut microbiota, we repeated the analysis after
stratification by mode of delivery (Table 3 and Figure 3).
Among children delivered vaginally, both measures of
diversity were significantly higher in controls than in cases
at the age of 1 month, with a non-statistically significant
difference at 4 months. Among children born by cesarean
section, controls had a significantly higher Shannon index
at age 4 months of age, with no significant difference at 1
month. Odds ratios were not calculated due to the small
number of subjects in each subgroup.
Mixed effects linear regression modeling was used to
directly evaluate the behavior of bacterial diversity over
time, with an interaction term included to assess whether
the effect of time differed between cases and controls.
Both models are illustrated in Figure 4. For the number of
bands, there was no difference between cases and controls
at 1 month of age. Controls acquired an average of 1.3
bands from age 1 month to age 4 months (p = 0.09),
whereas cases only increased by 0.1 bands (p = 0.87); this
resulted in a significant difference by age 4 months, with
controls having on average 2.6 more bands than cases (p
= 0.04). For the Shannon index model, controls had a sig-
nificantly higher diversity than cases at 1 and 4 months of
age, as previously described. During that period, H'
increased an average of 0.11 among controls (p = 0.04),
whereas the increase among cases was not significant (p =
0.32).
Discussion
DGGE is a method to assess bacterial microbiota that is
culture-independent and is based on electrophoresis of
denaturated bacterial 16S rDNA genotypes. Using the
number of electrophoretic bands and the Shannon index
as markers of gut microbial diversity, we found that a
reduced fecal bacterial diversity is associated with an
increased risk of physician-diagnosed eczema in early life.
These findings extend those of a recent report by Wang
and colleagues of an inverse association between bacterial
diversity of the gut microbiota at 1 week of age and
eczema diagnosed by the age of 18 months in European
infants, using terminal restriction fragment length poly-
morphism (T-RFLP) and temporal temperature gradient
electrophoresis (TTGE)[9]. Our results suggest that differ-
ences in microbial diversity of the gut between children
who will and will not develop eczema in infancy persist
up to age 4 months and in fact increase during the first
months of life.
An inverse association between family size and hay fever
led to the hypothesis that reduced microbial exposure in
early life increases the risk of developing allergic diseases
(the "hygiene hypothesis") [4,19]. Several potential
mechanisms have been proposed. TH2 cells promote aller-
Denaturating gradient gel electrophoresis (DGGE) Figure 1
Denaturating gradient gel electrophoresis (DGGE). 
Stool samples were processed to extract 16S rDNA, the V2–
V3 region was amplified by PCR, and denaturating gradient 
gel electrophoresis (DGGE) was performed using a standard 
protocol. For each lane, representing a single sample, the 
number of bands was counted and the Shannon index of 
diversity H' was calculated.Clinical and Molecular Allergy 2008, 6:11 http://www.clinicalmolecularallergy.com/content/6/1/11
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gen-specific responses via cytokines that increase produc-
tion of IgE, eosinophilia, and mast cell proliferation
[20,21]. In neonates, the immune system is skewed
towards a TH2 profile [22], and it has been postulated that
a decreased microbial exposure increases the risk of atopy
because of an insufficient shift towards a more balanced
TH1/TH2 response ("missing immune deviation")[20,23].
TREG cells, a newly characterized group of immune-modu-
latory T cells, suppress TH1 and TH2 activity by several
mechanisms [24-26]. Early antigen exposure may influ-
ence TREG activity [27].
To date, no specific microbe or microbial product respon-
sible for these observations has been confidently identi-
fied. The gut is the most important source of postnatal
microbial stimulation of the immune system [28]. In
experimental models, neonate mice with sterile gastroin-
testinal tracts do not develop a normal TH1/TH2 balance
[29]; reintroduction of bacteria normalizes such balance
[30,31]. Exposure of murine TREG cells to lipopolysaccha-
ride stimulates their activity by expression of Toll-like
receptors [32]. Murosaki [33] and Shida [34] have dem-
onstrated that certain species of Lactobacillus decrease in
vivo production of IgE in mice. Recently, Forsythe and col-
leagues reported that oral L. reuteri decreased eosinophilia
and allergen-induced airway responsiveness in a murine
model [35].
Human studies of the gut microbiota and allergies have
yielded conflicting results. Adlerberth et al. found no asso-
ciation between any of 11 fecal bacterial groups and atopy
Number of bands and Shannon diversity index in all subjects Figure 2
Number of bands and Shannon diversity index in all subjects. Controls had a higher number of bands at age 4 months 
(p = 0.06), and a higher Shannon index both at 1 (p = 0.01) and 4 months of age (p = 0.02).
Table 2: Fecal microbial diversity at ages 1 and 4 months, and 
eczema1 at age 6 months.
Odds ratio2 (95% CI)
Age Unadjusted Adjusted3
DGGE bands4 1 month 0.61 (0.28–1.13) 0.52 (0.19–1.08)
4 months 0.25 (0.04–0.87) 0.19 (0.01–0.87)
Shannon index5 1 month 0.30 (0.08–0.80) 0.23 (0.04–0.71)
4 months 0.15 (0.01–0.66) 0.08 (0.01–0.58)
1Defined as maternal report of physician-diagnosed eczema at or 
before 6 months of age
2Odds ratio of having eczema if fecal microbial diversity (number of 
bands or Shannon index) increases from the mean value for cases to 
the mean value for controls (e.g. from 3.8 to 4.8 bands at 1 month, 
etc).
3Adjusted for mode of delivery and maternal history of atopy. 
Adjusted odds ratios were not significantly different than unadjusted 
ones.
4Number of denaturating gradient gel electrophoresis (DGGE) bands 
in each sample
5Shannon diversity index (H') calculated using the relative intensity of 
all bands within each sampleClinical and Molecular Allergy 2008, 6:11 http://www.clinicalmolecularallergy.com/content/6/1/11
Page 6 of 9
(page number not for citation purposes)
in a cohort of European children [7]. On the other hand,
Penders and colleagues found an association between C.
difficile in stool samples at age 1 month and several mark-
ers of atopy in 957 Dutch infants [8]. Small clinical trials
have found that oral supplementation of probiotics con-
taining different species of lactobacilli and bifidobacteria
result in reduced severity of eczema [36-38]. Both murine
models and human studies have failed to isolate specific
bacteria associated with atopy in a consistent manner.
Rather than attempting to reduce the cause of these abnor-
malities in the immune system to the level of a specific
causative organism, a systems biology approach would
suggest the key factor is the alteration of the gut microbi-
ota as a whole.
Number of bands and Shannon diversity index by mode of delivery Figure 3
Number of bands and Shannon diversity index by mode of delivery: Controls delivered vaginally had a higher Shan-
non index than cases at 1 month (p = 0.04) but not at 4 months; index for controls delivered by C-section was similar to cases 
at 1 month, but higher at 4 months (p = 0.04).
Table 3: Fecal microbial diversity at ages 1 and 4 months, and eczema1 at age 6 months, stratified by mode of delivery
Vaginal Delivery2 Cesarean Section2
Means Means
Age Eczema Controls p-value3 Eczema Controls p-value3
DGGE bands4 1 month 3.60 5.20 0.05 4.00 4.57 0.75
4 months 4.20 7.75 0.26 3.50 5.67 0.12
Shannon index5
1 month 0.50 0.83 0.04 0.56 0.70 0.16
4 months 0.63 0.94 0.18 0.56 0.90 0.04
1Defined as parental report of physician-diagnosed eczema at or before 6 months of age
2There was no difference in microbial diversity when comparing delivery modes regardless of eczema status (p > 0.90)
3Mann-Whitney U-test p-value
4Number of denaturating gradient gel electrophoresis (DGGE) bands in each sample
5Shannon diversity index (H') calculated using the relative intensity of all bands within each sampleClinical and Molecular Allergy 2008, 6:11 http://www.clinicalmolecularallergy.com/content/6/1/11
Page 7 of 9
(page number not for citation purposes)
An alternate plausible explanation for the observed asso-
ciation between an anomalous gut microbiota and
eczema is that the abnormalities in the immune system
that lead to the disease (e.g., failure to develop a balanced
TH1/TH2 response by age 1 year, lack of a normal TREG
activity, etc.) prevent the acquisition or preservation of a
"normally diverse" gut microbiota. The decreased bacte-
rial diversity and the development of eczema would be
parallel consequences of the same underlying mecha-
nisms. However, a causal relationship is supported both
by experimental data demonstrating the restitution of
normal immune function and decreased inflammation in
mice after reintroduction of bacteria [30-35], and by
human studies demonstrating prevention or improve-
ment of atopic dermatitis in infants after probiotic admin-
istration [36-39].
Of interest, a reduced microbial diversity has been impli-
cated in various diseases. Li and colleagues found that the
microbial diversity of the oral cavity was significantly
reduced in children with severe early-childhood caries[40]
when compared to controls. A potential explanation for
this finding is that certain groups of bacteria supplant or
dominate the plaque flora in individuals with caries,
whereas caries-free individuals have a more diverse flora
with no subgroup predominance. Abnormalities in quan-
tity or composition of the fecal microbiota have been
linked to diseases such as ulcerative colitis [41], Crohn's
disease[42,43], and celiac disease [44,45].
The association between atopic eczema and subsequent
development of asthma in children is well recognized
[46]. A recent study by Burgess et al showed that a history
of childhood eczema is also associated with new-onset of
asthma later in life and with asthma persisting into mid-
dle age [47]. Being able to identify infants at risk and pre-
vent the development of eczema would not only lessen
the burden of the disease itself, but could also help iden-
tify children at risk for and perhaps help prevent asthma
in those infants later in childhood and into adulthood.
Non-culture dependent methods such as DGGE have bet-
ter sensitivity to detect certain bacterial species than stool
cultures, which may provide incomplete data because of
inability to detect non-culturable bacteria. These new
methods provide a more accurate view of the bacterial
community and allow for the study of the whole system,
rather than focusing on specific species. Although it
would have been ideal to perform full genotyping and
sequencing of bacterial DNA, we were limited by our sam-
ple size. Similarly, potential differences in the relation
between microbial diversity and eczema by mode of deliv-
Predictions from mixed effects linear regression models Figure 4
Predictions from mixed effects linear regression models. (Note: cases in red; controls in black). Number of bands: The 
increase in the number of bands tends to be more substantial in controls (p = 0.09) than in cases (p = 0.87); by age 4 months, 
controls have on average 2.6 bands more than cases. Shannon index: H' increases significantly in controls (p = 0.04) but not in 
cases (p = 0.32); at 1 month of age the index for controls is 0.22 higher, and at 4 months it is 0.33 higher. (*p < 0.05; see Table 
1).Clinical and Molecular Allergy 2008, 6:11 http://www.clinicalmolecularallergy.com/content/6/1/11
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ery must be interpreted with caution because of the small
sample size of our study. History of antibiotic usage by the
infants was not associated with the diagnosis of eczema;
although information was missing on 2 subjects (1 con-
trol and 1 case), sensitivity analysis for the missing data
showed no change in the results.
Conclusion
We found a significant inverse association between fecal
bacterial diversity and eczema in early life. In addition, we
found a significant increment in fecal bacterial diversity
from ages 1 to 4 months in healthy children, but not in
children who developed eczema by age 6 months. Further
research is needed to investigate these findings, including
larger sample sizes to elucidate the effect of time and other
factors known to be associated with bacterial diversity
and/or atopy, DGGE standardization and genotyping to
identify groups of bacteria and patterns associated with
the development of eczema, and long-term follow-up to
provide information regarding development of other
atopic diseases such as asthma.
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